Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotyping of Blood Samples to Detect Autoimmune Signature Following Immunotherapy With Pembrolizumab

NCT02909348 is registered in ClinicalTrials.gov with Royal Free Hospital NHS Foundation Trust as lead sponsor.

NCT NCT02909348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02909348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotyping of Blood Samples to Detect Autoimmune Signature Following Immunotherapy With Pembrolizumab
Lead sponsor
Royal Free Hospital NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
October 31, 2019
Enrollment
25 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, neoplasms